We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 328 → 2 (-326)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
325
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$46.5M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.34B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.02B
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$907M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$858M
5
BlackRock
BlackRock
New York
-$638M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
126
VOYA Investment Management
Georgia
– -$6.58M -20,783 Closed
State of New Jersey Common Pension Fund D
127
State of New Jersey Common Pension Fund D
New Jersey
– -$6.56M -20,720 Closed
AGC
128
Angelo Gordon & Co
New York
– -$6.33M -20,000 Closed
ACM
129
Atika Capital Management
New York
– -$6.33M -20,000 Closed
DekaBank Deutsche Girozentrale
130
DekaBank Deutsche Girozentrale
Germany
– -$6.33M -20,000 Closed
HM
131
Harvest Management
New York
– -$6.33M -20,000 Closed
CIS
132
Capital International Sarl
California
– -$6.21M -19,624 Closed
GLAM
133
Gardner Lewis Asset Management
Pennsylvania
– -$6.18M -19,517 Closed
D.E. Shaw & Co
134
D.E. Shaw & Co
New York
– -$6.06M -19,131 Closed
SSA
135
Schonfeld Strategic Advisors
New York
– -$5.94M -18,762 Closed
CI
136
Capital International
California
– -$5.77M -18,241 Closed
VI
137
Versor Investments
New York
– -$5M -15,785 Closed
Treasurer of the State of North Carolina
138
Treasurer of the State of North Carolina
North Carolina
– -$4.99M -15,770 Closed
FTCM
139
First Trust Capital Management
Illinois
– -$4.87M -15,400 Closed
Janus Henderson Group
140
Janus Henderson Group
United Kingdom
– -$4.85M -15,332 Closed
CC
141
Centiva Capital
New York
– -$4.76M -15,036 Closed
Ohio Public Employees Retirement System (OPERS)
142
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$4.71M -14,891 Closed
PCM
143
Prelude Capital Management
New York
– -$4.62M -14,581 Closed
CSS
144
Cubist Systematic Strategies
Connecticut
– -$4.61M -14,560 Closed
EAM
145
Erste Asset Management
Austria
– -$4.58M -14,470 Closed
AG
146
Algert Global
California
– -$4.49M -14,176 Closed
CII
147
Capital International Inc
California
– -$4.31M -13,632 Closed
BNP Paribas Financial Markets
148
BNP Paribas Financial Markets
France
– -$4.31M -13,611 Closed
Prudential Financial
149
Prudential Financial
New Jersey
– -$4.19M -13,244 Closed
VF
150
Virtu Financial
New York
– -$4.14M -13,073 Closed
4 5
6
7 8

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.